TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 52 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $2,794,000 | -8.8% | 1,992 | -99.9% | 0.66% | -13.7% |
| Q1 2015 | $3,062,000 | +5.7% | 2,062,000 | +97532.6% | 0.76% | -7.9% |
| Q4 2014 | $2,896,000 | +3.1% | 2,112 | -99.9% | 0.83% | +2.5% |
| Q3 2014 | $2,808,000 | -0.7% | 2,179,000 | -1.4% | 0.81% | +0.5% |
| Q2 2014 | $2,828,000 | -1.5% | 2,209,000 | -2.0% | 0.81% | -5.1% |
| Q1 2014 | $2,871,000 | +10.9% | 2,253,000 | -7.2% | 0.85% | +7.1% |
| Q4 2013 | $2,589,000 | -4.7% | 2,427,000 | -6.9% | 0.79% | -10.6% |
| Q3 2013 | $2,717,000 | -7.8% | 2,608,000 | -6.9% | 0.89% | -14.9% |
| Q2 2013 | $2,948,000 | – | 2,801,000 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 83,413,000 | $130,650,000 | 6.13% |
| AEGON USA Investment Management, LLC | 6,000,000 | $9,368,000 | 2.35% |
| MACKAY SHIELDS LLC | 24,370,000 | $38,152,000 | 2.07% |
| INCOME RESEARCH & MANAGEMENT | 4,374,000 | $6,829,000 | 1.11% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 20,000 | $20,347,000 | 0.99% |
| SHENKMAN CAPITAL MANAGEMENT INC | 5,269,000 | $8,264,000 | 0.82% |
| Mitsubishi UFJ Securities Holdings Co., Ltd. | 325,000 | $511,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,299,000 | $14,598,000 | 0.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 14,543,000 | $23,021,000 | 0.35% |
| CSS LLC/IL | 3,750,000 | $5,893,000 | 0.35% |